IN8BIO, INC. Files 8-K: Material Agreements & Equity Sales
Ticker: INAB · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-action
TL;DR
IN8BIO filed an 8-K detailing material agreements, equity sales, and changes to security holder rights.
AI Summary
On April 27, 2025, IN8bio, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and material modifications to the rights of security holders. This 8-K filing includes financial statements and exhibits.
Why It Matters
This filing indicates significant corporate actions, including new agreements and equity transactions, which could impact IN8bio's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- IN8bio, Inc. (company) — Registrant
- April 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39692 (filing_number) — Commission File Number
- 82-5462585 (ein) — IRS Employer Identification No.
FAQ
What type of material definitive agreement did IN8bio, Inc. enter into?
The filing states that IN8bio, Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 27, 2025.
What are the key items reported in this 8-K filing?
The key items reported are: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, and Financial Statements and Exhibits.
What is IN8bio, Inc.'s state of incorporation and fiscal year end?
IN8bio, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What was IN8bio, Inc.'s former company name?
IN8bio, Inc.'s former company name was Incysus Therapeutics, Inc., with a date of name change on May 10, 2018.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding IN8BIO, INC. (INAB).